Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

  19 December 2022

The Netherlands is a country with a low prevalence of multidrug-resistant organisms (MDRO), including carbapenemase-producing Enterobacterales (CPE), carbapenemase-producing  (CPPA), carbapenem-resistant  complex (CRAB) and meticillin-resistant  (MRSA) [14]. Active MDRO screening and infection prevention measures (e.g. isolation of suspected colonised patients) applies to all patients admitted to a Dutch hospital who have recently been admitted to a hospital abroad (< 2 months ago for > 24 h) or resided in a centre for asylum seekers. Since March 2022, there has been an emergence of MDRO in the Netherlands in persons originating from Ukraine. Persons from whom isolates were obtained were receiving hospital care in the Netherlands and are henceforth referred to as patients. Here, we describe the epidemiology and genetic analysis of MDRO from patients from Ukraine in the Netherlands.

Further reading: Eurosurveillance
Author(s): Romy D Zwittink et al
Effective Surveillance  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
WordPress PopUp Plugin